SNDL
SNDL Inc.NASDAQHealthcare$1.36+2.26%ClosedMarket Cap: $352.5M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.45
P/S
0.51
EV/EBITDA
8.78
DCF Value
$-66.51
FCF Yield
11.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
27.3%
Operating Margin
-0.5%
Net Margin
-1.7%
ROE
-1.4%
ROA
-1.2%
ROIC
-0.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $252.5M | 27.8% | $13.7M | $9.4M | $0.04 | — |
| FY 2025 | $946.4M | 27.3% | $-4.4M | $-15.8M | $-0.06 | — |
| Q3 2025 | $244.2M | 26.3% | $-11.1M | $-13.3M | $-0.05 | — |
| Q2 2025 | $244.8M | 27.6% | $5.0M | $2.9M | $0.01 | — |
| Q1 2025 | $204.9M | 27.6% | $-12.1M | $-14.7M | $-0.06 | — |
| Q4 2024 | $257.7M | 26.7% | $-76.1M | $-67.1M | $-0.26 | — |
| FY 2024 | $920.4M | 26.1% | $-103.8M | $-94.8M | $-0.38 | — |
| Q3 2024 | $236.9M | 26.6% | $-18.5M | $-19.3M | $-0.07 | — |
| Q2 2024 | $228.1M | 25.5% | $-4.8M | $-5.8M | $-0.02 | — |
| Q1 2024 | $197.8M | 25.5% | $-4.4M | $-2.6M | $-0.01 | — |
| Q4 2023 | $248.4M | 23.1% | $-84.9M | $-82.8M | $-0.31 | — |
| FY 2023 | $909.0M | 20.9% | $-163.2M | $-172.7M | $-0.65 | — |